Our Blogs – Pinnacle Life Science
British Medical Journal: Extending Rivaroxaban Treatment After Distal DVT Reduces Further Clot Risk
A study published today in The BMJ found that patients who received the anti-clotting medi ...
Read moreDoes Dapagliflozin Reduce The Risk Of Cardiovascular Death?
It is well established that patients with type-2 diabetes have a higher risk of cardiovasc ...
Read moreStudy: Apixaban Tied To Lower Risk Of Gastrointestinal Bleeding
In medical science, anticoagulants play a significant role. Specific patients require anti ...
Read moreHow Is The Anti-Cancer Drug Market Prospering At USD 256.66 Billion?
As per the reports, 1 out of 10 men and 1 out of 8 women in India have cancer. After cardi ...
Read moreWith More Oncology Data At Our Fingertips, Interpretation Tools Are Key
Medicine has seen a new future with technological advancement. It has become inevitable to ...
Read moreESR Test: What To Know About Erythrocyte Sedimentation Rate?
Erythrocyte Sedimentation Rate, or the ESR test, shows signs of inflammation in the body. ...
Read moreA Glimpse At The Global Pharmaceutical Market – Pharma Business Operations
Efficient and robust business strategies of top cdmo companies in India define the long-te ...
Read more3 Ways To Prevent Supply Chain Risk In The Pharmaceutical Industry
Did you know the global value of pharmaceutical items traded has increased sixfold in the ...
Read moreA simple guide on using blood thinners safely
Blood thinners are medications that inhibit the formation of blood clots. They also preven ...
Read moreAdvancements in the Pharmaceutical Oncology
Cancer therapy of top oncology pharma companies in India continues to progress. Efficient ...
Read more